R E S E A R C H


              INKlings
           June 2000 • Medical University of South Carolina • Volume IX • No 6


...
June 2000                                         Research INKlings
Additional information is available on the Internet at...
Research INKlings                                             June 2000

which will lead to the development of centers whe...
June 2000                                        Research INKlings
announcement published in the NIH Guide of April       ...
Research INKlings                                              June 2000

                                                ...
June 2000                                       Research INKlings
                                                        ...
Research INKlings                                              June 2000

Title: Clinical Research Operations and Monitori...
June 2000                                       Research INKlings
involving the class participants and previous graduates....
Research INKlings                                            June 2000

function, including the study of cellular interact...
June 2000                                        Research INKlings
acquisition or maintenance of drug-directed behavior;  ...
Research INKlings                                           June 2000

provide advanced training in experimental methods. ...
June 2000                                                          Research INKlings

  Institutional Support for Research...
Upcoming SlideShare
Loading in...5
×

June 2000 NL-final final copy

385

Published on

Published in: Health & Medicine, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
385
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Transcript of "June 2000 NL-final final copy"

  1. 1. R E S E A R C H INKlings June 2000 • Medical University of South Carolina • Volume IX • No 6 Opportunities & Deadlines AIDS The NIAID’s Division of AIDS (DAIDS) is seeking proposals from prospective contractors for the provision of Title: HIV Vaccine Research and Design immunologic evaluations for "...(i) the assessment of the Agency: NIH - NIAID / National Institute of Allergy & quality and specificity of immunologic reagents of Infectious Diseases importance to AIDS clinical trials and preclinical studies; Identification: PAR-00-093 (ii) the evaluation of immunologic agents and strategies Deadline: October 10, 2000, 2001, and 2002. with potential anti-HIV activity; (iii) the examination of novel immune modulators for effects on HIV replication in The NIAID has several ongoing programs to support vitro; and (iv) the evaluation of immune reactivities of any phase of development of vaccines against HIV or patients receiving experimental anti-HIV therapies." The AIDS. This one, recently re-announced, seeks applications purpose of these activities is to offer comprehensive for P01 (program project) grants to support two or more support for other contracts directed toward the discovery interrelated multidisciplinary projects which have a central and development of novel therapeutic agents for the research focus or objective; at least one core with prevention and treatment of HIV and other infections. The resources supporting the projects must also be included. single contract will be for a period of seven years. The This is a special case, the usual requirement being at least RFP should be on the Internet at <http:// three projects and one or more cores. Examples of areas www.niaid.nih.gov/contract/>. Contact Ms. Lois Eaton, considered among those appropriate to address under this Contract Specialist, 301/496-0611; FAX: 301/402-0972. program are identified as "...HIV antigen processing, correlates of immunity, animal model development, DNA vaccination, studies of the structure of HIV immunogens, development of virus and bacterial vaccine vectors, studies ALLERGY & IMMUNOLOGY targeting initial infection (dendritic cells). This includes extensive modeling of vaccine concepts in non-human Title: Postdoctoral Fellowships in Immunology primates. Clinical studies involving humans would not be Agency: The Irvington Institute for Immunological considered appropriate for this PA. In addition, vaccine Research research focused solely on therapeutic application is not Identification: none responsive to this announcement. The safety evaluation of Deadline: July 7, 2000 immunogens in infected animals may be included if these studies directly support the development of a prophylactic "The mission of the Irvington Institute for vaccine." Contact Dr. Steve Bende, Division of AIDS, at Immunological Research is to be the leading private non- 301/435-3756; FAX: 301/435-6511. profit supporter of outstanding postdoctoral research in immunology." It awards 12 fellowships each year to support M.D. or Ph.D. scientists, usually with no more Title: Specialized in Vitro Immunological Evaluations of than three years of postdoctoral laboratory experience, to Strategies to Combat HIV/AIDS conduct up to three years of basic immunologic research Agency: NIH - NIAID / National Institute of Allergy & under the guidance of a senior investigator in an Infectious Diseases outstanding academic or medical setting in the U.S. The Identification: RFP: NIH-NIAID-DAIDS-01-18 stipends are $37,000, $40,000, and $43,000 per year for the Deadline: August 1, 2000 three years. There is no citizenship requirement. Office of Research Development q Medical University of South Carolina -1-
  2. 2. June 2000 Research INKlings Additional information is available on the Internet at Deadline: not known <http://www.irvingtonresearch.org>. Contact Alma Ramon, Fellowship Coordinator, at 212/576-1005; FAX: The Chemical and Physical Carcinogenesis Branch, 212/576-1006. Division of Cancer Biology, of the NCI is seeking a contractor to establish and maintain a Chemical Carcinogen Reference Standard Repository. The BEHAVIORAL SCIENCES contractor is to characterize and document the compounds, develop analytical protocols to ensure their purity, store Title: Young Investigator Award them, maintain a computerized inventory, and distribute Agency: NARSAD / National Alliance for Research on them to the scientific community as required. The contract Schizophrenia and Depression is to be for a five-year period. The RFP for this initiative is Identification: none expected to be on the Internet at <http://amb.nci.nih.gov/ Deadline: July 25, 2000 rfp.htm>. Contact Annmarie L. Keane, Contract Specialist, at 301/435-3814. The National Alliance for Research on Schizophrenia and Depression funds a program, the Young Investigator Award, which provides up to $30,000 per year for one or Title: Cancer Prevention Research Small Grant Program two years to enable promising investigators in at least the Agency: NIH - NCI / National Cancer Institute second year of a postdoctoral fellowship when they apply Identification: PAR-00-025 to extend their fellowship period or to begin an Deadline: Ongoing, with deadlines of July 20, November independent career as a junior faculty member. Basic or 20, and March 20, through March 20, 2002 clinical investigators are eligible, but the research must be relevant to schizophrenia, major affective disorders, or other serious mental illnesses. An established investigator The NCI encourages submission of R03 (small grant) in the field of endeavor must serve as mentor. Two other applications for support of pilot studies in the area of NARSAD programs are the "Independent Investigator cancer prevention which the Institute considers to include Award" and the "Distinguished Investigator Award." development of chemoprevention agents and biomarkers, Information from the Alliance is available on the Internet early detection, and application of nutritional approaches. at <http://www.narsad.org>. Contact Audra Moran, A major objective of the program is to increase the number Director, Research Grants Program, at 516/829-5576 or of investigators working in this field, but established 516/829-0091; FAX: 516/487-6930. investigators are also encouraged to submit applications to support the testing of new ideas. Under this program support is limited to three years and the total budget for the CANCER grant period is limited to $100,000, with a limit of $50,000 for any single year. The Program Announcement for this Title: Melanoma Research Grant initiative, which was published in the NIH Guide of Agency: Melanoma Research Foundation December 13, 1999, identifies about 20 broad areas of Identification: none potential research, divided among the categories of early Deadline: July 1, 2000 detection, chemoprevention, and nutrition. Basic and clinical areas are included. Peer review will be conducted The Melanoma Research Foundation makes awards by groups convened by the NCI. Contact Barry Portnoy, of up to $20,000 yearly for researchers with either Ph.D. Ph.D., Division of Cancer Prevention, at 301/496-9569; or M.D. degrees, at the assistant professorship level, and FAX: 301/496-9931. lacking strong grant support from government sources. Support for postdoctoral fellows is also considered. Contact The Melanoma Research Foundation; 1111 Title: Planning Grants: In Vivo Cellular and Molecular Cornwall, Suite 209; Bellington, WA 98225. Imaging Centers (Pre - ICMICs) Agency: NIH - NCI / National Cancer Institute Identification: RFA: CA-01-010 Title: Chemical Carcinogen Reference Standard Deadline: August 18, 2000, with letter of intent requested Repository by July 14, 2000 Agency: NIH - NCI / National Cancer Institute Identification: N02-CB-07008-16 The NCI is seeking applications for planning grants -2- Office of Research Development q Medical University of South Carolina
  3. 3. Research INKlings June 2000 which will lead to the development of centers where the respectively techniques of molecular recognition are melded with those of modern high resolution imaging in ways which will These two funding components of the NIH are enable investigators and practicing oncologists to study the seeking applications for phased innovations awards to molecular and cellular characteristics of cancer by non- support research aimed at the development of novel invasive techniques in vivo. Institutions where the imaging technologies for early detection, screening, facilities for such studies are available and the integration diagnosis, or image-guided treatment of cancer and other is now in place may wish to await an upcoming initiative diseases. It is expected that this initiative will encourage for the funding of the centers under the P50 mechanism high risk/high gain research exploiting the knowledge of rather than applying for the planning grant under this P20 the molecular bases of cancer and other diseases to develop planning grant mechanism. Applicants may not apply for imaging methods useful in vivo. This grant mechanism as both. The planning under this initiative is to be conducted proposed will utilize the R21 (exploratory/developmental) in two phases over a three-year period with annual budgets grant to support up to two years of investigation, with of $400,000 in total costs. Six awards of planning grants is annual budgets of up to $100,000 in directs costs per year, anticipated. Applicants are expected to bring together followed by an additional two years of support under the expertise in many disciplines such as imaging sciences, R33 grant (exploratory/developmental phase 2) chemistry, radiopharmaceutical chemistry, cell and mechanism, with larger budgets. If feasibility can be molecular biology, pharmacology, computer science, documented by earlier studies, research may be requested biomedical engineering, immunology, and neuroscience for up to three years under the R33 mechanism alone. Pre- and to provide resources for their multidisciplinary clinical and human investigations are encouraged. Contact research. The activities of Phase I, which should take no Barbara Y. Croft, Ph.D., Biomedical Imaging Program, longer than six months, include establishment of an NCI, at 301/496-9531; FAX: 301/480-5785; or Abraham organizational structure, development of formal Levy, Ph.D., Biomedical Technology, NCRR, at 301/435- mechanisms for scientific creative interactions among the 0755; FAX: 301/480-3659. participants, identification of equipment and supplies needed and mechanisms for utilization of them, and development of mechanisms for selection and Title: Planning Grant for Minority Institution/Cancer implementation of projects. Phase II will be devoted to Center Collaboration selection of two or three highly-interactive developmental Agency: NIH - NCI / National Cancer Institute; and projects which will be used to determine feasibility and ORMH / Office of Research on Minority Health gather preliminary data and thereby to demonstrate the Identification: RFA: CA-01-003 validity of the organizational structure and function. The Deadline: July 26, 2000, with letter of intent requested by application is expected to contain no more than six short June 8, 2000 (three- or four-page) descriptions of possible pilot projects, which may or may not be the ones actually selected later during Phase I of funded proposals. The RFA contains The NCI and ORMH of the NIH are seeking detailed instructions for preparing applications; included applications for P20 (planning) grants submitted as pairs, are some rather specific requirements. One is that each one from a Minority-Serving Institution (MSI), the other lead investigator must be the PI of a major peer-reviewed from a partner which is a Cancer Center, not necessarily an research project, activities which will establish the NCI-designated Cancer Center. The MSI may have a expertise for the role proposed in this application. The medical school or an institution awarding graduate degrees RFA was published in the NIH Guide of May 5, 2000. in focused areas. The purpose of the program is to allow Contact Anne E. Menkens, Ph.D., Biomedical Imaging planning over a period of up to three years to initiate pilot Program, at 301/496-9531; FAX: 301/480-5785. projects involving collaboration between the two institutions, which are mutually beneficial. The major emphasis must be on pilot projects which involve research or research training, but some planning efforts may also be Title: Development of Novel Imaging Technologies directed toward cancer education and outreach to minority (Phased Innovation Award) communities. The expectation is that the program will lead Agency: NIH - NCI / National Cancer Institute; and to an array of future research, training, and education NCRR / National Center for Research Resources grants. It is anticipated that ten awards will be made, each Identification: PAR-00-089 involving a pair of grants with total annual budgets in the Deadline: July 19, 2000 and March 16, 2001, with letters range of $100,000 to $250,000. This program has some of intent requested by June 14, 2000 or February 9, 2001, special features and requirements, presented in the Office of Research Development q Medical University of South Carolina -3-
  4. 4. June 2000 Research INKlings announcement published in the NIH Guide of April Environmental Health Sciences 28,2000. One requirement is that pilot projects proposed Identification: ES-00-003 for the Cancer Center must focus on problems relevant to Deadline: July 10, 2000 areas of cancer disparity in minority populations. The projects from the MSI may be on any research area related These three agencies of the federal government, all of to cancer. Contact Sanya A. Springfield, Ph.D., NCI, at which have a major interest in the toxicity of chemical 301/496-7344; FAX: 301/402-4551; or Brian Kimes, agents, are jointly seeking applications for "...innovative Ph.D., NCI, at 301/496-8537; FAX: 301/402-0181. experimental approaches and computational, statistical, or predictive strategies for assessing the impact of chemical mixtures that focus on the mechanistic basis for chemical Title: Department of Defense Ovarian Cancer Research interactions and related health effects." Applications are to Program for Fiscal Year 2000 utilize a form similar to the NIH R01 mechanism or an Agency: U.S. Army equivalent one used by the EPA. Three years of support Identification: CBD-OCR-0428 with annual budgets of up to $250,000 in total costs may Deadline: September 13, 2000 be requested. The agencies seek theoretically based models which may prove useful in predicting the As part of its Congressionally Directed Medical interactions among binary, ternary, and higher Research Programs (CDMRP) the U.S. Army Medical combinations of mixtures. A complete description of the Research and Materiel Command is once more seeking goals of this program and the nature of approaches being proposals for contracts to support research and research sought are contained in the full announcement of the training related to ovarian cancer. The research areas being program, available on the Internet at <http://es.epa.gov/ encouraged in this initiative are these, as relevant to ncerqa/rfa/mixtures00.html>, where directions for epithelial ovarian carcinoma and/or primary peritoneal downloading an application form are also given. Some of carcinoma: "(1) etiology, (2) early detection/diagnosis, (3) the emphasis is contained in the following isolated preclinical therapeutics, and (4) quality of life." Two types quotations from that announcement: "...the approach of of support are offered, Ovarian Cancer New Investigator this RFA is to support research to develop innovative and Awards and Program Project Awards. The New credible statistical, computational, and predictive Investigator Awards are aimed at funding investigators, approaches for assessing risks from mixtures of new ones at the assistant professorship level or the chemicals..."; "...specific testing of mixtures of chemicals equivalent with no more than six years of experience or will not be supported in this program except in cases where experienced ones new to the field of ovarian cancer the testing is used as an example or model of approaches or research, at a level of about $300,000 in direct costs over a methodologies to be developed." It is clear that three-year period. Applicants are expected to have multidisciplinary research will be needed to achieve the preliminary or pilot data. The Program Project Awards overall goals, although individual grants might emphasize offer support for two to four years, at a level up to $2 more limited aspects. Areas of expertise identified include million in total costs, to establish new interdisciplinary statistics, epidemiology, pharmacokinetics, toxicology, programs of research on ovarian cancer, the programs to animal models, cell culture, and molecular biology. consist of two to four individual research projects and one Contacts from the EPA are Chris Saint, Ph.D., at 202/564- or two supporting core facilities. Preference will be given 6909; e-mail: <saint.chris@epa.gov>; and Thomas Veirs to applications from institutions not currently having at 202/564-6831; e-mail: <veirs.thomas@epa.gov>; from program projects for ovarian cancer research. Complete the CDC (NIOSH), Michael Galvin, Ph.D., at 404/639- descriptions of this overall initiative is available on the 1533; e-mail: <mtg3@cdc.gov>; and, from the NIEHS, Internet at <http://cdmrp.army.mil>. Contact Craig D. Claudia Thompson, Ph.D., at 919/541-4638; e-mail: Lebo, Contracting Officer, at 301/619-2036. <thompso1@niehs.nih.gov>. ENVIRONMENTAL HEALTH GASTROENTERIC DISORDERS Title: Complex Chemical Mixtures: FY 2000 Science to Title: Research and Research Training Grants Achieve Results (STAR) Program Agency: Crohn’s and Colitis Foundation of America Agency: EPA / U.S. Environmental Protection Agency; (CCFA) CDC - NIOSH / National Institute for Occupational Safety Identification: none and Health; and NIH - NIEHS / National Institute of Deadline: July 1, 2000 -4- Office of Research Development q Medical University of South Carolina
  5. 5. Research INKlings June 2000 projects related to cystic fibrosis. Contact the Association The CCFA supports basic and clinical research and at 212/924-9174; FAX: 212/675-3577. research career development related to inflammatory bowel disease (IBD). The following programs have deadlines of July 1, 2000: MISCELLANEOUS CCFA Career Development Awards. These awards are for MD’s or PhD’s with at least two years of postdoctoral Title: Cooperative Agreement for Collaborating Centers research experience related to IBD. Awards are for two for Public Health Law years, renewable competitively for a third year, with Agency: CDC - Centers for Disease Control and annual stipends of $40,000 plus $20,000 in support for Prevention research and travel. The recipient is expected to devote Identification: PA 00053 full-time to the research, including up to 20% of relevant Deadline: July 14, 2000, with letter of intent requested by clinical activity. A sponsor is required who will offer June 23, 2000 advice and guidance to the developing investigator. First Awards. These awards offer three years of support at The CDC is encouraging the submission of up to $60,000 per year for beginning investigators having applications for cooperative agreements for the faculty status, with a doctoral degree and past mentored development and operation of one to three collaborating research experience related to IBD. The funds are for centers to "...work toward establishing a strong legal research support and partial support for a stipend, as long foundation for effective public health practice through as the total research support is adequate. training and education, collaboration, communication, and Research Grant Awards. These awards offer two years of analysis. Specific goals of the collaborating center(s) will support, renewable for a third year competitively, at up to be to : (a) improve the effectiveness of laws as a type of $80,000 per year, which may be used for research support public health intervention; (b) improve the quality, and salary based on percentage of effort. These awards are accessibility, and scientific basis of information about laws intended to provide short-term support for individuals related to public health; (c) improve the knowledge of embarking on a career in biomedical research related to laws related to public health among public health IBD who have not yet received major funding from other practitioners, the legal community, and public policy sources but who are expected to use this funding to makers; and (d) stimulate contributions by organizations generate additional data to improve their competitive and individuals to improvement of the legal foundation for position. public health." The announcement emphasizes that the The CCFA also offers postdoctoral fellowships and student term "law" is to be interpreted broadly in this context, research fellowships at several educational levels. None of encompassing other public health policies, regulations, etc. the programs of the CCFA have specific citizenship The CDC encourages applications from consortia requirements, although the applicant must offer proof of composed of schools of public health or medicine, law legal work status. All programs seem to have deadlines on schools, and schools of public policy and/or public July 1 and January 1 each year. Further information is administration. Under the cooperative agreement available on the CCFA Website at <http://www.ccfa.org>. mechanism the CDC plans to participate in the planning Contact the Research and Education Department, CCFA, at and conduct of activities in this program. The award 212/685-3440 or 800/932-2423; FAX: 212/779-4098. recipient is expected to "a. Identify and evaluate existing training and continuing education in the area of public health law for public health practitioners, professionals in the legal community, and HEART, LUNG, AND public policy makers; develop training and continuing BLOOD DISEASES education to address identified gaps; conduct training using both existing and newly developed training and Title: Research Grants in Cystic Fibrosis continuing education materials, with priority on training Agency: Cystic Fibrosis Association of Greater New York for public health practitioners. Newly developed training Identification: none and continuing education materials should support core Deadline: June 21, 2000, for a letter of intent; if accepted, competencies as outlined in Essential Service 6 of ‘The application will be sent. Public Health Workforce: An Agenda for the 21st Century’..."see <http://www.health.gov/phfunctions/ The Cystic Fibrosis Association of Greater New York pubhlth.pdf>. "b. Research laws that affect public health, addressing the offers grants of up to $35,000 for the support of research Office of Research Development q Medical University of South Carolina -5-
  6. 6. June 2000 Research INKlings the "New Investigator Development (NID) Award", following general objectives: (1) identify and analyze designed to encourage physicians/scientists "...who have existing and proposed laws relevant to public health; (2) not previously conducted neuromuscular disease research" assess the distribution, provisions, and trends in laws that to develop therapies for the neuromuscular diseases affect public health; (3) develop and implement a research targeted by the MDA. These awards, limited to $100,000 agenda for public health law with broad stakeholder per year, are "...highly competitive and limited in number." involvement; (4) synthesize and translate research on laws Information on these programs and application forms are affecting public health; and (5) disseminate results and available on the Internet at <http://www.mdausa.org>. findings from analyses. Contact the Grants Manager - Research Department at 520/ "c. Stimulate collaboration and communication among organizations active in public health, law, public policy, 529-2000; FAX: 520/529-5454. and related fields by developing, linking, and disseminating information regarding laws and public health through an Internet website and/or other means; convening Title: NASA Center for Biology Inspired Technology conferences and other meetings; and producing, (NCBIT) sponsoring, and disseminating reports, analyses, and other Agency: NASA / Goddard Space Flight Center publications." Identification: 10-03498 About $300,000 is available in FY2000 to fund the first Deadline: Early July 2000 year of the one to three awards, which are anticipated to have three-year award periods. Contact Anthony D. The Goddard Space Flight Center is seeking Moulton, Ph.D., Associate Director for Policy, Program proposals for establishment of a single "NASA Center for Analysis and Academic Programs, Public Health Practice Biology Inspired Technology (NCBIT)", to be funded Program Office, at 770/488-2404; FAX: 770/488-2420. under a cooperative agreement. Quoting from the announcement of this program, which was published in the Commerce Business Daily of April 27, 2000, "An objective of the NCBIT is to develop an understanding of Title: MDA Research Grants Program where and how the unique attributes of biological systems Agency: Muscular Dystrophy Association (MDA) can be applied to challenges of spacecraft design and Identification: none operations as well as the development of tools to promote Deadline: June 15 and December 15 for requesting an safe and effective human work in the exploration of space. application which must be submitted one month later, July These technologies will enable novel missions and 15 or January 15 research capabilities, hitherto not envisioned, and will dramatically impact the human safety and productivity, affordability, and scientific outcome of space exploration. The MDA funds research aimed at developing It is also anticipated that such technologies will have broad treatments for "...the muscular dystrophies and related applicability to the solution of health, safety and improved diseases of the neuromuscular system. These are the human performance in different hazardous and medical muscular dystrophies (among which are Duchenne and care activities on Earth." Examples of systems of interest Becker); motor neuron diseases (including ALS and include: "1. Medical Monitor and Intervention Systems SMA); the peripheral nerve disorders (CMT and (non-invasive, automated, etc.) 2.Sensor Systems for Life Friedreich’s ataxia); inflammatory myopathies; disorders and Environmental Detection 3. Closed loop LifeSupport of the neuromuscular junction; metabolic diseases of Systems 4. Human- centered Information Processing muscle as well as other myopathies." Applicants for any Systems 5. Human-centered prognostic and self-correcting type of research grant must have a scientific or clinical systems 6. Spacecraft Guidance and Data Acquisition doctoral degree and be affiliated with an educational, Systems 7. Spacecraft Repair Systems Advances..." More research, or medical institution. There are three types of information on this program, including deadlines for any awards, any of which may be awarded for one, two, or required preproposal and the final proposal, should be three years. The "Research Grants" are for experienced available on the Internet at <http://nais.msfc.nasa.gov/cgi> investigators and are unlimited with respect to budget. and/or <http://genesis.gsfc.nasa.gov/ncbit/home.html>. "Development Grants" are aimed at members of research Contact Lori M. Levine, Contract Specialist, at 301/286- teams in the laboratories of senior investigators under whose guidance the applicants will conduct appropriate 7164; FAX: 301/286-1773. research projects. An applicant must have at least 18 months of postdoctoral experience when applying. These awards are limited to $35,000 per year. A third category is -6- Office of Research Development q Medical University of South Carolina
  7. 7. Research INKlings June 2000 Title: Clinical Research Operations and Monitoring Center Agency: NIH - NIAID / National Institute of Allergy & Title: Public Health Leadership Institute Infectious Diseases Agency: CDC - Centers for Disease Control and Identification: RFP: NIH-NIAID-DAIDS-01-15 Prevention Deadline: October 10, 2000 Identification: PA 00041 Deadline: July 15, 2000, with a brief letter of intent The NIAID has issued an RFP seeking proposals for a required by June 15, 2000 five-year contract to support the monitoring of clinical studies which the Division of Acquired Immunodeficiency The CDC is seeking applications for a cooperative Syndrome (DAIDS) supports by grants in programs for agreement to plan and conduct a leadership institute aimed which no network monitoring mechanism exists. The at increasing the knowledge and skills of state and local contractor will support the operational, regulatory, and site- health officials and other public health professionals. monitoring needs for projects which include "...therapeutic, Quoting from the announcement of this program, the vaccine and non-vaccine prevention clinical trials and "...long-term objectives...are to: epidemiologic, pathogenesis, and behavioral studies..." in "1. Provide an annual forum for discussions and the critical the U.S. and abroad. The essence of the requirement seems analysis of current public health issues. embodied in this statement taken from the announcement: "2. Develop a network of public health leaders who can "For selected clinical research studies and trials, the provide ongoing support to the public health infrastructure Contractor will be asked to: a) provide expert assistance following attendance at the program. and advice to facilitate protocol development; b) monitor "3. Strengthen the relationship between public health the ability of the site(s) to initiate and conduct studies in practice and academia by providing a model for such accordance with current U.S. and international guidelines interaction. on human subjects protection and good clinical practice "4. Enhance and develop leadership skills and abilities of and laboratory guidelines; c) provide guidance and participants in areas that are vital to the operation of their training to sites for study implementation and conduct; and health agencies." d) provide administrative and logistical support including "The core faculty of the program will consist of recognized establishing a data base that captures essential information leaders form academia. Leaders from the private sector, about the clinical research planned and conducted by professional and voluntary organizations, government DAIDS non-network grantees." The RFP should be agencies and legislative staffs will also be recruited when available on the Internet at <http://www.niaid.nih.gov/ specialized expertise is required." contract>. Contact Donald E. Collie, Contract Specialist, The single award is expected to be for five years, with at 301/496-0992; FAX: 301/480-5253. annual budgets of about $500,000. This project is to be planned and executed in collaboration with the staff of the CDC; the recipient is expected to travel to that agency about twice each year to discuss the program. Very briefly Title: Parapsychology Research summarized, the recipient of this award is expected to Agency: The Parapsychology Foundation, Inc. carry out these activities: Identification: none organize and coordinate the planning activities of a Deadline: see below nationwide steering committee composed of representatives from various designated agencies; develop This Foundation funds projects in the field of and present the leadership program; demonstrate how the parapsychology. It considers proposals for original curriculum will be likely to achieve the goals of the research, study, and experiments. Areas include telepathy, program; "provide a conference facility for at least one on- precognition, psychokinesis, and related phenomena. site forum to engage in discussions and critical analysis of There is no deadline. The Foundation also offers a $3,000 current health issues as well as continuing discussions scholarship to college-level students who are interested in during the year-long experience"; develop a network of pursuing academic study of parapsychology, and who have public health officials; develop a model for interaction a demonstrable prior interest in the field as supported by between public health practice and academia; provide for writings and letters of reference. Information on the CCU or CME credits; provide expenses for participants to Parapsychology Foundation is available on the Internet at attend the on-site week; develop an evaluation plan; <http://www.parapsychology.org>. Contact the Foundation develop a funding plan for sustaining the program; and at 212/628-1550; FAX: 212/628-1559. develop a plan for continued collaborative efforts Office of Research Development q Medical University of South Carolina -7-
  8. 8. June 2000 Research INKlings involving the class participants and previous graduates. contact the Huntington’s Disease Society of America and The full announcement for this program is on the Internet The Wills Foundation; the three foundations communicate at <http://www.cdc.gov/od/pgo/funding/00041.htm> with one another about applicants. Contact Donna C. Carmichael, Public Health Practice Program Office, at 770/488-2417; e-mail: <dcc0@cdc.gov>. Title: NINDS Administrative Supplements for DNA Microarray Analysis NEUROLOGICAL DISORDERS Agency: NIH - NINDS / National Institute of Neurological Disorders & Stroke Title: Grants and Fellowships Related to Huntington’s Identification: NS-00-007 Disease Deadline: July 3, 2000 Agency: Hereditary Disease Foundation Identification: none The NINDS has made about $2.5 million available to Deadline: Ongoing, with deadlines of August 15, October support supplements to currently funded NINDS grants 15, and February 15 for most programs, with a letter of where DNA microarray analyses will provide clearly intent and request for application submitted any time up relevant data and where at least one more year of until a month before a deadline. committed support remains. Any type of major research grant is eligible, with total budgets for the supplements This Foundation funds basic research studies, two limited as follow: for R01s - $50,000 (two modules); for types of postdoctoral fellowships, and the special P01s and P50s - $100,000 (four modules). The funds are Lieberman Award to promote new endeavors furthering the to be expended for the use and analyses of arrays, understanding of Huntington’s disease. The Hereditary including microarrays, reagents, scanners, and data Disease Foundation Grants are usually for one year, analysis. Purchases of services from vendors or renewable, with a budget of no more than $50,000. These institutional facilities are acceptable as are appropriate grants are aimed at supporting pilot projects which, with salary expenditures. The announcement requests that data this support, may generate findings which will support obtained with these supplemental funds be shared with the grant applications from other sources. The areas of special scientific community; plans for doing so will be one interest to the Foundation as described under each of its criterion for evaluating requests. Contact Thomas Miller, programs are "trinucleotide expansions, animal models, Ph.D., Technology Development, at 301/496-1779; FAX: gene therapy, neurobiology and development of the basal 301/402-1501. ganglia, cell survival and death, and intercellular signaling in striatal neurons." The Milton Wexler Postdoctoral Fellowship program provides support for two years, Title: The Role of Parkin and Related Proteins in renewable for a possible third year, and provides $43,000 Parkinson’s Disease (PD) for salary, $12,000 for supplies, and $2,000 for travel for Agency: NIH - NINDS / National Institute of the first year. They are restricted to research that is highly Neurological Disorders & Stroke relevant to curing Huntington’s disease. The John J. Identification: RFA: NS-01-005 Wasmuth Postdoctoral Fellowships are for one year, Deadline: August 17, 2000, with letter of intent requested renewable for a second, and offer annual stipends varying by July 15, 2000 from $28,500 to $43,000, depending upon the career level of the applicant, plus a $5,000 allowance for supplies. The The NINDS is seeking R01 grant applications to Lieberman Award is a one- or two-year research grant support research on parkin and related proteins, studies budgeted at up to $75,000 per year to support proposals which seek to clarify mechanisms relevant to related to the treatment and cure of Huntington’s disease. neurodegeneration. The Institute intends to commit $1 The single deadline for this latter program is October 15, million in FY 2001 for the first year of support for up to with a one-page letter of intent and request for application four grants. The following investigations are suggested in to be submitted at least one month prior to that date. the RFA: Information on this foundation and its awards is on the "o More expansive genetic studies on the parkin and UHC- Internet at <http://www.hdfoundation.org>. Contact Dr. L1 mutations in PD families, including those not yet Allan Tobin, Scientific Director, at 310/458-4183; FAX: screened for these mutations. 310/458-3937. Scientists interested in this area of research "o Creation of parkin models in various animal systems, are also urged by the Hereditary Disease Foundation to including mice, flies, etc. to better understand parkin -8- Office of Research Development q Medical University of South Carolina
  9. 9. Research INKlings June 2000 function, including the study of cellular interactions of NUTRITION parkin with other proteins. "o Structure/function studies of the RING finger domain in Title: Grants in Human Nutrition - Research and parkin or related PD proteins, including their possible role Education in ubiquitination. Agency: Allen Foundation, Inc. "o Role of parkin or related PD proteins as potential Identification: none transcriptional activators." Deadline: none Contact Diane D. Murphy, Ph.D., Program Director, at 301/496-5680; FAX: 301/480-1080. The Allen Foundation of Midland Michigan awards grants to support programs in human nutrition in the areas of education, training, and research. Preference is given Title: Neurotoxin Exposure Treatment Research Program when matching funds are available. The policies and Agency: U.S. Army priorities of the Foundation, as stated on its website at Identification: CBD-NRP-0502 <http://www.tamu.edu/baum/allen.html>, may be Deadline: September 20, 2000, with letter of intent summarized as providing research grants or other support encouraged by August 16, 2000 related to nutritional problems anywhere in the world, efforts to train children and young adults to improve their The U.S. Army Medical Research and Materiel health and development, improving nutrition in pregnancy Command is seeking proposals for contracts to support and early postnatal life, training educators in nutrition research on "...the pathophysiology and treatment of fields, promoting dissemination of relevant information by neurodegenerative diseases, including Parkinson’s disease, various means including support for publications, and and including environmental and stress exposure factors providing emergency measures to deal with hunger and encountered in military operations which may be malnutrition. Support for nutrition courses for health neurotoxic or lead to neurodegenerative conditions." Such professionals falls within its purview. It has also supported research has potential for benefiting the armed forces in projects to promote volunteer activities and student dealing with threat and operational hazards and also for nutritional organizations in colleges as well as research on improving the knowledge and treatment of aspects of nutrition of possible relevance to Alzheimer’s neurodegenerative diseases. The announcement in the disease. Contact Dale Baum, Secretary, The Allen Commerce Business Daily of May 4, 2000 gives this brief Foundation, Inc., at 517/832-5678; FAX: 517/832-8842. description of the research being encouraged by this solicitation: "We solicit proposals on a broad range of basic and applied science, including but not limited to these areas of interest: (1) influence of environmental SUBSTANCE ABUSE factors such as exposure to toxic substances, head injury, shock, radiofrequency radiation and chronic stress in the Title: Development of Behavioral Methods for Drug mediation of neural cell death, (2) development and Abuse Studies in the Mouse validation of new approaches to early detection of Agency: NIH - NIDA / National Institute on Drug Abuse neurodegenerative disease, (3) new therapeutic strategies Identification: RFA: DA-01-002 for the treatment of neurodegenerative disease, including Deadline: August 22, 2000, with letter of intent requested neural cell transplantation, neuroprotection, and alteration by July 21, 2000 of cell biology through gene regulation and other novel methods." Peer review of projects will be conducted with The NIDA seeks R21 (exploratory/developmental) scientific merit and military relevance being considered. grant applications to support projects designed to facilitate About $9 million is available to support projects for their the increased use of mouse models for behavioral research total project periods, which will generally be two to four related to drug abuse. These grants will be limited to three years. Some ten projects will be supported at levels not to years of support with annual budgets of up to $100,000 in exceed $100,000 each, which are designated as "concept direct costs. It is anticipated that 10 - 15 grants will be exploration" proposals. These are to support pilot projects, funded under this initiative. The RFA identifies the where preliminary data are scant, and to support following examples of some specific areas or interest: investigators new to the field. Contact Craig D. Lebo, "1. The development of methods for studying in the mouse Contracting Officer, at 301/619-2036. a variety of behaviors involved in or related to drug taking, drug seeking, or motivational processes. The proposed research could include the study of: impulsive behavior; Office of Research Development q Medical University of South Carolina -9-
  10. 10. June 2000 Research INKlings acquisition or maintenance of drug-directed behavior; academic surgery. They provide stipends of $25,000 behavioral models of drug relapse, including stress- or cue- annually for two years. At least one award is to be for induced relapse; narrowing of behavioral repertoire; research directed toward surgical wound healing. A third compulsive behavior; reproductive or affiliative behavior; category, Faculty Research Fellowships, will probably be or behavioral measures of drug sensitization, tolerance, or announced with a deadline later in the year. Some withdrawal. Methods used in other animal species, such as additional information is available on the Internet at <http:/ the rat, could be adapted to the mouse, or the proposed /www.facs.org>. Contact Barbara Hone, Scholarships research could exploit species-typical behaviors of the Division, at 312/664-4050; Fax: 312/440-7014. mouse. "2. Phenotypic characterization of behaviors that are related to drug taking and drug seeking or indicative of Title: UICC International Cancer Fellowships related central motivational states in different laboratory Agency: International Union Against Cancer (UICC) mouse strains or in genetically altered mice. Identification: none "3. The development of methods for rapid and/or Deadline: Various, depending upon the program; see automated phenotypic screening, such as automated below. methods for measuring drug directed or related behaviors, or for measuring behavioral responsivity to drugs of abuse The UICC Fellowships Programme offers short, or potential therapeutic agents. medium, and long-term fellowships for investigators, "4. The development of novel methods of drug self clinicians, and nurses actively engaged in cancer research administration, which are less technically difficult and or clinical oncology to enable the awardees to spend time more easily implemented than traditional methods, for outside their home countries pursuing research and study rapid screening of behavioral phenotype." relevant to their research or patient care activities. Some Contact Susan Volman, Ph.D., Division of Neurosciences fellowships are to promote exchanges between specific & Behavioral Research, Behavioral Neurobiology countries; most are to promote professional activities Research Branch, at 301/435-1315; FAX: 301/594-6043; involving any appropriate countries. Short synopses of or Minda Lynch, Ph.D., Division of Neurosciences & some programs follow: Behavioral Research, Behavioral Sciences Research NOVARTIS UICC Translational Cancer Research Branch, at 301/435-1322; FAX: 301/594-6043. Fellowships (TCRF). A single fellowship is offered each year to allow an experienced scientist or clinician to spend TRAINING & CAREER a year working in a foreign country with other experienced DEVELOPMENT cancer specialists pursuing new ideas related to cancer, including work on prevention and therapy. One purpose is to promote an enduring collaboration. The award is Title: Fellowships, Scholarships, and Career Development $55,000. The deadline is December 1. Awards in Surgery American Cancer Society UICC International Fellowships Agency: American College of Surgeons for Beginning Investigators (ACSBI). These one-year Identification: none awards of $35,000 are offered to some eight to ten Deadline: Ongoing, with upcoming deadline of July 1, scientists each year to "...fund 12 months long basic, 2000, for a letter of intent, followed by a deadline of translational or clinical research projects in the areas of August 1, 2000 for the full application. epidemiology, prevention, causation, detection, diagnosis, treatment, and psycho-oncology that foster a bi-directional The American College of Surgeons offers several flow of knowledge, experience, expertise, and innovation types of awards for support of surgical investigators at to and from the USA. Candidates should be in the early various stages of their career development. The George stages of their careers and applications that are geared to H.S. Clowes, Jr., MD, FACS, Memorial Research the development of specific cancer control measures in Development Award provides support for five years at developing and central and east European countries are $40,000 per year to a surgeon-investigator who has particularly encouraged." These are funded by the completed a residency or fellowship in general surgery or American Cancer Society. The deadline is December 1. in a surgical specialty within the past five years. Yamagiwa-Yoshida Memorial UICC International Cancer Applicants with significant research funding are preferred. Study Grants (YY). This program funds about 15 one- to There are several Resident Research Scholarships to be three-month fellowships at about $9,000 each to allow awarded to surgical residents who have completed two scientists from one country to travel and work in another years of postdoctoral training and wish to pursue careers in country to exploit complementary materials or skills and to - 10 - Office of Research Development q Medical University of South Carolina
  11. 11. Research INKlings June 2000 provide advanced training in experimental methods. the award, under the K22 award, is limited to $140,000 Applicants should be experienced investigators. The per year in direct costs. Entry into the program at NIDA deadlines are July 1 and January 1. may take place at any mutually agreeable time. Transition UICC International Cancer Technology Transfer to the extramural program requires an application for the Fellowships (ICRETT). This program funds each year K22 award from the extramural institution with letters about 130 one- to three- month long research or clinical from the Scientific Director of the Intramural Research projects for qualified investigators or clinicians to teach or Program and mentor at NIDA. The usual specific acquire "...up-to-date research techniques, advanced deadlines are applicable. This program requires that the clinical management, diagnostic and therapeutic skills, and applicant contact the Institute at an early stage since transfer appropriate technology." The awards average acceptance into the intramural phase at NIDA is the first $3,000 each. Applications are accepted at any time. step. Contact, for programmatic issues, Lucinda L. Miner, Trish Greene UICC International Oncology Nursing Ph.D., Office of Science Policy and Communications, at Fellowships (IONF). These fellowships are awarded to 301/443-6071; FAX: 301/443-6277; or, for information English-speaking nurses from developing and East on the intramural phase, Stephen J. Heishman, Ph.D., European countries to allow them to spend one to three Associate Director for Education and Training, Intramural months abroad involved in projects on education related to Research Program, at 410/550-1547; FAX: 410/550-1849. subjects such as cancer prevention, early detection, patient counseling, drug handling, palliative care, pain assessment, and quality of life. The awards average $2,800 each. The deadline is November 1. Information on these and other activities of the UICC is Title: Postdoctoral Research Fellowships for Basic and available on the Internet at <http://www.uicc.ch>. Contact Physician Scientists Mrs. Brita M. Baker, Fellowships Department, UICC, 3, Agency: The Cancer Research Fund of the Damon rue du Conseil-General, 1205 Geneva, Switzerland, at (41 Runyon - Walter Winchell Foundation 22) 809 1840; FAX: (41 22) 809 1810. Identification: none Deadline: Ongoing, with deadlines of August 15, December 15, and March 15 Title: The NIDA Scholars Program Agency: NIH - NIDA / National Institute on Drug Abuse This Foundation’s Cancer Research Fund makes Identification: PAR-00-092 awards to support basic and clinical scientists who have Deadline: See below. recently completed a Ph.D. or clinical degree (<1 yr, level 1 award) or their residency and clinical training (<3 yr, level 2 award) and are embarking on a mentored period of The NIDA has announced the availability of a two- research on cancer causes, mechanisms, therapies, and phase program to provide outstanding scientists with prevention. The Fellowships are awarded for up to three scientific or health professional doctoral degrees and with years with level 1 stipends progressing from $35,000 to no more than five years of postdoctoral experience salary $44,000 per year, level 2 from $55,000 - 57,000. All and research support while they undergo a four- to six-year awards include a yearly allowance of $2,000 for the period of collaborative and mentored research, two to four laboratory where the research is conducted. Candidates are years in the intramural program of the NIDA and then a generally expected to work in an academic institution in final two years in an extramural institution under a K22 the U.S.; however, if adequately justified, the research (Career Transition) Award. The primary purpose of this may be abroad or in a government lab in this country. program is to increase the number of well-trained Foreign candidates may apply, but they must do their investigators in the areas of research relevant to the research in the U.S. The Fund also makes five awards at a mission of the National Institute on Drug Abuse. It also higher level of support ($100,000 per year for three years) makes the research programs at NIDA and the scientists to past recipients of the Fellowships who apply from conducting this research available to help train these clinical departments in some institutions invited to submit talented junior scientists to the benefit of NIDA scientists an application. Further information on these award and the research community. During the intramural period, programs and on The Cancer Research Fund is available which must be arranged with staff members of the on the Internet at <http://www.cancerresearchfund.org>. Intramural Research Program, the Scholar is supported at a Contact Sarah J. Caddick, Ph.D., Director of Award level up to $150,000 per year. Under exceptional Programs, Damon Runyon - Walter Winchell Foundation, circumstances this period may be shorter than the usual at 212/697-9550; FAX: 212/697-4950. two-year minimum. The support for the final two years of Office of Research Development q Medical University of South Carolina - 11 -
  12. 12. June 2000 Research INKlings Institutional Support for Research through the URC (University Research Committee) The University provides support to strengthen the research capabilities of the faculty and to provide research training for residents interested in pursuing an academic career. Additional information and questions may be directed to the Office of Research and Sponsored Programs at 792-3838. Deadline, Review and Funding Dates Deadline Institutional Resident Interim Funding Review Funding Application Application Request Decision by Dates April 1 April 15 May 1 June 15 July 1 August 1 August 15 September 1 October 15 December 1 December 1 December 15 January 2 February 15 April 1 NIH STANDARD RECEIPT DATES AND REVIEW AND AWARD CYCLES TYPES OF APPLICATIONS CYCLE I CYCLE II CYCLE III Institutional National Research Service Awards* January 10 May 10 September 10 All Academic Research Enhancement Awards, except those involving AIDS-related research January 25 May 25 September 25 New Research Grants, Conferences, and Research Career Awards. February 1 June 1 October 1 All Program Project* and Center Grants* February 1 June 1 October 1 Interactive Research Project Grants February 15 June 15 October 15 Competing Continuation, Supplemental, and Revised Grants March 1 July 1 November 1 Individual National Research Service Awards (Standard)** April 5 August 5 December 5 All AIDS-Related Grants May 1 September 1 January 2 SCIENTIFIC MERIT REVIEW June-July Oct-Nov. February-March ADVISORY COUNCIL REVIEW Sept-Oct Jan-Feb May-June EARLIEST PROJECT START DATE December April July *For these specialized grant applications, consult with the appropriate PHS awarding component prior to the preparation of an application, particularly if the requested budget exceeds $500,000. **The National Research Service Award Individual Predoctoral Fellowships for Minority Students and Students with Disabilities have special receipt dates. Receipt Date Policy * An unsolicited, investigator-initiated application is considered on time if it is either (1) received by or (2) mailed on or before the published receipt date and a proof of mailing is provided. Proof of timely mailing consists of a legibly dated U.S. Postal Service postmark or a dated receipt from a commercial carrier or the U.S. Postal Service. Private metered postmarks are not acceptable. This policy also applies to unsolicited AIDS-related applications and to AREA applications. * Solicited applications and proposals must be received by the specified date. However, an application received after the deadline may be acceptable if it carries a legible proof-of-mailing date assigned by the carrier and the proof-of-mailing is not later than one week prior to the deadline date. Solicited applications include those in response to Requests for Applications (RFAs); Program Announcements (PAs) with specified receipt dates (dates other than the standard ones specified in the chart below), such as Small Business Innovation Research (SBIR), and Small Business Technology Transfer (STTR); and Requests for Proposals (RFPs). * Applications may be hand-delivered to the Rockledge Center, which is open 24 hours per day. To obtain a signed receipt for a hand-delivered application, the package must be delivered no later than 5:00 p.m. (Monday through Friday). * When a receipt date falls on a weekend or holiday, the receipt date will be the following business day. EDITORIAL STAFF Peggy Schachte..........Editor Billy Baggett, PhD.....Science Editor Trisha Addison...........Production Manager Phone (843) 792-5828 FAX (843) 792-1657 - 12 - Office of Research Development q Medical University of South Carolina

×